Neurogenic maturation of human dental pulp stem cells following neurosphere generation induces morphological and electrophysiological characteristics of functional neurons

Stem Cells and Development

Volumn 24, Issue 3, 2015, Pages 296-311

  Gervois, Pascal ^a   Struys, Tom ^a   Hilkens, Petra ^a   Bronckaers, Annelies ^a   Ratajczak, Jessica ^a   Politis, Constantinus ^a,b   Brône, Bert ^a   Lambrichts, Ivo ^a   Martens, Wendy ^a  

^a HASSELT UNIVERSITY   (Belgium)

^b UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; BRAIN DERIVED NEUROTROPHIC FACTOR; CYCLIC AMP; MICROTUBULE ASSOCIATED PROTEIN 2; NERVE CELL ADHESION MOLECULE; NERVE GROWTH FACTOR; NEUROMODULIN; NEUROTROPHIN 3; SYNAPSIN I; SYNAPTOPHYSIN; TETRODOTOXIN; TETRYLAMMONIUM; VASCULOTROPIN; VOLTAGE GATED POTASSIUM CHANNEL; VOLTAGE GATED SODIUM CHANNEL; CULTURE MEDIUM; ION CHANNEL; NERVE PROTEIN;

ACTION POTENTIAL; ADULT; ARTICLE; CELL COMMUNICATION; CELL DIFFERENTIATION; CELL MATURATION; CELL ULTRASTRUCTURE; CONTROLLED STUDY; CYTOPLASM; DENTAL PULP STEM CELL; ELECTRON MICROSCOPY; ELECTROPHYSIOLOGY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; MALE; MICROENVIRONMENT; NERVOUS SYSTEM DEVELOPMENT; NEUROSPHERE; NUCLEOTIDE SEQUENCE; PATCH CLAMP TECHNIQUE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; SIGNAL TRANSDUCTION; STEM CELL; ADOLESCENT; BIOSYNTHESIS; CELL CULTURE; CELL CULTURE TECHNIQUE; CELL SEPARATION; CELL SHAPE; CULTURE MEDIUM; CYTOLOGY; GENETICS; MULTICELLULAR SPHEROID; NERVE CELL; PHARMACOLOGY; PHYSIOLOGY; PROCEDURES; SECRETION (PROCESS); TOOTH PULP; TUMOR MICROENVIRONMENT; YOUNG ADULT;

ACTION POTENTIALS; ADOLESCENT; ADULT; CELL COMMUNICATION; CELL CULTURE TECHNIQUES; CELL SEPARATION; CELL SHAPE; CELLS, CULTURED; CELLULAR MICROENVIRONMENT; CULTURE MEDIA; DENTAL PULP; FEMALE; HUMANS; ION CHANNELS; MALE; MICROSCOPY, ELECTRON; NERVE TISSUE PROTEINS; NEUROGENESIS; NEURONS; PATCH-CLAMP TECHNIQUES; SPHEROIDS, CELLULAR; YOUNG ADULT;

EID: 84921441850     PISSN: 15473287     EISSN: 15578534     Source Type: Journal    
DOI: 10.1089/scd.2014.0117     Document Type: Article

References (101)

1. Dua T, M Cumbrera, C Mathers and S Saxena. (2006). Global burden of neurological disorders: estimates and projections. In: Neurological Disorders: Public Health Challenges. Campanini B, ed. World Health Organization, Geneva, Switzerland, pp 27-40.
2. National Institute of Neurological Disorders and Stroke rt-PA Study Group. (1995). Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 333:1581-1588.
3. Hacke W, G Donnan, C Fieschi, M Kaste, R von Kummer, JP Broderick, T Brott, M Frankel, JC Grotta, et al. (2004). Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials. Lancet 363:768-774.
4. Nygaard HB. (2013). Current and emerging therapies for Alzheimer's disease. Clin Ther 35:1480-1489.
5. United Nations, Department of Economic and Social Affairs. (2002). Magnitude and speed of population ageing. In: World Population Ageing 1950-2050. Population Division, DESA, United Nations, New York, NY, pp 11-13.
6. Lindvall O and Z Kokaia. (2006). Stem cells for the treatment of neurological disorders. Nature 441:1094-1096.
7. Arvidsson A, T Collin, D Kirik, Z Kokaia and O Lindvall. (2002). Neuronal replacement from endogenous precursors in the adult brain after stroke. Nat Med 8:963-970.
8. Eriksson PS, E Perfilieva, T Bjork-Eriksson, AM Alborn, C Nordborg, DA Peterson and FH Gage. (1998). Neurogenesis in the adult human hippocampus. Nat Med 4: 1313-1317.
9. Lundberg C, A Martinez-Serrano, E Cattaneo, RD McKay and A Bjorklund. (1997). Survival, integration, and differentiation of neural stem cell lines after transplantation to the adult rat striatum. Exp Neurol 145(2 Pt 1):342-360.
10. Liu S, Y Qu, TJ Stewart, MJ Howard, S Chakrabortty, TF Holekamp and JW McDonald. (2000). Embryonic stem cells differentiate into oligodendrocytes and myelinate in culture and after spinal cord transplantation. Proc Natl Acad Sci U S A 97:6126-6131.
11. Johansson CB, S Momma, DL Clarke, M Risling, U Lendahl and J Frisen. (1999). Identification of a neural stem cell in the adult mammalian central nervous system. Cell 96:25-34.
12. Reynolds BA and S Weiss. (1992). Generation of neurons and astrocytes from isolated cells of the adult mammalian central nervous system. Science 255:1707-1710.
13. McLaren A. (2001). Ethical and social considerations of stem cell research. Nature 414:129-131.
14. Nunes MC, NS Roy, HM Keyoung, RR Goodman, G McKhann, 2nd, L Jiang, J Kang, M Nedergaard and SA Goldman. (2003). Identification and isolation of multipotential neural progenitor cells from the subcortical white matter of the adult human brain. Nat Med 9:439-447.
15. Waddington RJ, SJ Youde, CP Lee and AJ Sloan. (2009). Isolation of distinct progenitor stem cell populations from dental pulp. Cells Tissues Organs 189:268-274.
16. Gronthos S, M Mankani, J Brahim, PG Robey and S Shi. (2000). Postnatal human dental pulp stem cells (DPSCs) in vitro and in vivo. Proc Natl Acad Sci U S A 97:13625-13630.
17. Shi S and S Gronthos. (2003). Perivascular niche of postnatal mesenchymal stem cells in human bone marrow and dental pulp. J Bone Miner Res 18:696-704.
18. Hilkens P, P Gervois, Y Fanton, J Vanormelingen, W Martens, T Struys, C Politis, I Lambrichts and A Bronckaers. (2013). Effect of isolation methodology on stem cell properties and multilineage differentiation potential of human dental pulp stem cells. Cell Tissue Res 353:65-78.
19. Struys T, M Moreels, W Martens, R Donders, E Wolfs and I Lambrichts. (2011). Ultrastructural and immunocytochemical analysis of multilineage differentiated human dental pulp-and umbilical cord-derived mesenchymal stem cells. Cells Tissues Organs 193:366-378.
20. Dominici M, K Le Blanc, I Mueller, I Slaper-Cortenbach, F Marini, D Krause, R Deans, A Keating, D Prockop and E Horwitz. (2006). Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8:315-317.
21. Stevens A, T Zuliani, C Olejnik, H LeRoy, H Obriot, J Kerr-Conte, P Formstecher, Y Bailliez and RR Polakowska. (2008). Human dental pulp stem cells differentiate into neural crest-derived melanocytes and have label-retaining and sphere-forming abilities. Stem Cells Dev 17:1175-1184.
22. Pierdomenico L, L Bonsi, M Calvitti, D Rondelli, M Arpinati, G Chirumbolo, E Becchetti, C Marchionni, F Alviano, et al. (2005). Multipotent mesenchymal stem cells with immunosuppressive activity can be easily isolated from dental pulp. Transplantation 80:836-842.
23. Martens W, E Wolfs, T Struys, C Politis, A Bronckaers and I Lambrichts. (2012). Expression pattern of basal markers in human dental pulp stem cells and tissue. Cells Tissues Organs 196:490-500.
24. Nosrat IV, CA Smith, P Mullally, L Olson and CA Nosrat. (2004). Dental pulp cells provide neurotrophic support for dopaminergic neurons and differentiate into neurons in vitro; implications for tissue engineering and repair in the nervous system. Eur J Neurosci 19:2388-2398.
25. Nosrat IV, J Widenfalk, L Olson and CA Nosrat. (2001). Dental pulp cells produce neurotrophic factors, interact with trigeminal neurons in vitro, and rescue motoneurons after spinal cord injury. Dev Biol 238:120-132.
26. Bronckaers A, P Hilkens, Y Fanton, T Struys, P Gervois, C Politis, W Martens and I Lambrichts. (2013). Angiogenic properties of human dental pulp stem cells. PLoS One 8:e71104.
27. Kiraly M, K Kadar, DB Horvathy, P Nardai, GZ Racz, Z Lacza, G Varga and G Gerber. (2011). Integration of neuronally predifferentiated human dental pulp stem cells into rat brain in vivo. Neurochem Int 59:371-381.
28. Iohara K, L Zheng, H Wake, M Ito, J Nabekura, H Wakita, H Nakamura, T Into, K Matsushita and M Nakashima. (2008). A novel stem cell source for vasculogenesis in ischemia: subfraction of side population cells from dental pulp. Stem Cells 26:2408-2418.
29. Sakai K, A Yamamoto, K Matsubara, S Nakamura, M Naruse, M Yamagata, K Sakamoto, R Tauchi, N Wakao, et al. (2012). Human dental pulp-derived stem cells promote locomotor recovery after complete transection of the rat spinal cord by multiple neuro-regenerative mechanisms. J Clin Invest 122:80-90.
30. Yamamoto A, K Sakai, K Matsubara, F Kano and M Ueda. (2014). Multifaceted neuro-regenerative activities of human dental pulp stem cells for functional recovery after spinal cord injury. Neurosci Res 78:16-20.
31. Leong WK, TL Henshall, A Arthur, KL Kremer, MD Lewis, SC Helps, J Field, MA Hamilton-Bruce, S Warming, et al. (2012). Human adult dental pulp stem cells enhance poststroke functional recovery through nonneural replacement mechanisms. Stem Cells Transl Med 1:177-187.
32. Jensen JB and M Parmar. (2006). Strengths and limitations of the neurosphere culture system. Mol Neurobiol 34:153-161.
33. Gritti A, P Frolichsthal-Schoeller, R Galli, EA Parati, L Cova, SF Pagano, CR Bjornson and AL Vescovi. (1999). Epidermal and fibroblast growth factors behave as mitogenic regulators for a single multipotent stem cell-like population from the subventricular region of the adult mouse forebrain. J Neurosci 19:3287-3297.
34. Reynolds BA and RL Rietze. (2005). Neural stem cells and neurospheres - re-evaluating the relationship. Nat Methods 2:333-336.
35. Xiong F, H Gao, Y Zhen, X Chen, W Lin, J Shen, Y Yan, X Wang, M Liu and Y Gao. (2011). Optimal time for passaging neurospheres based on primary neural stem cell cultures. Cytotechnology 63:621-631.
36. Caldwell MA, X He, N Wilkie, S Pollack, G Marshall, KA Wafford and CN Svendsen. (2001). Growth factors regulate the survival and fate of cells derived from human neurospheres. Nat Biotechnol 19:475-479.
37. Morsczeck C, F Vollner, M Saugspier, C Brandl, TE Reichert, O Driemel and G Schmalz. (2010). Comparison of human dental follicle cells (DFCs) and stem cells from human exfoliated deciduous teeth (SHED) after neural differentiation in vitro. Clin Oral Investig 14:433-440.
38. Sasaki R, S Aoki, M Yamato, H Uchiyama, K Wada, T Okano and H Ogiuchi. (2008). Neurosphere generation from dental pulp of adult rat incisor. Eur J Neurosci 27:538-548.
39. Widera D, WD Grimm, JM Moebius, I Mikenberg, C Piechaczek, G Gassmann, NA Wolff, F Thevenod, C Kaltschmidt and B Kaltschmidt. (2007). Highly efficient neural differentiation of human somatic stem cells, isolated by minimally invasive periodontal surgery. Stem Cells Dev 16:447-460.
40. Osathanon T, N Nowwarote and P Pavasant. (2011). Basic fibroblast growth factor inhibits mineralization but induces neuronal differentiation by human dental pulp stem cells through a FGFR and PLCgamma signaling pathway. J Cell Biochem 112:1807-1816.
41. Kiraly M, B Porcsalmy, A Pataki, K Kadar, M Jelitai, B Molnar, P Hermann, I Gera, WD Grimm, et al. (2009). Simultaneous PKC and cAMP activation induces differentiation of human dental pulp stem cells into functionally active neurons. Neurochem Int 55:323-332.
42. Arthur A, G Rychkov, S Shi, SA Koblar and S Gronthos. (2008). Adult human dental pulp stem cells differentiate toward functionally active neurons under appropriate environmental cues. Stem Cells 26:1787-1795.
43. Tatard VM, G D'Ippolito, S Diabira, A Valeyev, J Hackman, M McCarthy, T Bouckenooghe, P Menei, CN Montero-Menei and PC Schiller. (2007). Neurotrophindirected differentiation of human adult marrow stromal cells to dopaminergic-like neurons. Bone 40:360-373.
44. Encinas M, M Iglesias, Y Liu, H Wang, A Muhaisen, V Cena, C Gallego and JX Comella. (2000). Sequential treatment of SH-SY5Y cells with retinoic acid and brainderived neurotrophic factor gives rise to fully differentiated, neurotrophic factor-dependent, human neuron-like cells. J Neurochem 75:991-1003.
45. Constantinescu R, AT Constantinescu, H Reichmann and B Janetzky. (2007). Neuronal differentiation and longterm culture of the human neuroblastoma line SH-SY5Y. J Neural Transm Suppl (72):17-28.
46. Seidenfaden R, A Krauter and H Hildebrandt. (2006). The neural cell adhesion molecule NCAM regulates neuritogenesis by multiple mechanisms of interaction. Neurochem Int 49:1-11.
47. Rogers DA and NF Schor. (2013). Kidins220/ARMS depletion is associated with the neural-to Schwann-like transition in a human neuroblastoma cell line model. Exp Cell Res 319:660-669.
48. Bretschneider A, W Burns and A Morrison. (1981). "Popoff" technic. The ultrastructure of paraffin-embedded sections. Am J Clin Pathol 76:450-453.
49. Gerhardt LC, KL Widdows, MM Erol, A Nandakumar, IS Roqan, T Ansari and AR Boccaccini. (2013). Neocellularization and neovascularization of nanosized bioactive glass-coated decellularized trabecular bone scaffolds. J Biomed Mater Res A 101:827-841.
50. Mikulowska-Mennis A, TB Taylor, P Vishnu, SA Michie, R Raja, N Horner and ST Kunitake. (2002). High-quality RNA from cells isolated by laser capture microdissection. Biotechniques 33:176-179.
51. Nourbakhsh N, M Soleimani, Z Taghipour, K Karbalaie, SB Mousavi, A Talebi, F Nadali, S Tanhaei, GA Kiyani, et al. (2011). Induced in vitro differentiation of neural-like cells from human exfoliated deciduous teeth-derived stem cells. Int J Dev Biol 55:189-195.
52. Hamill OP, A Marty, E Neher, B Sakmann and FJ Sigworth. (1981). Improved patch-clamp techniques for highresolution current recording from cells and cell-free membrane patches. Pflugers Arch 391:85-100.
53. Schlett K, A Czirok, K Tarnok, T Vicsek and E Madarasz. (2000). Dynamics of cell aggregation during in vitro neurogenesis by immortalized neuroectodermal progenitors. J Neurosci Res 60:184-194.
54. Tarnok K, A Pataki, J Kovacs, K Schlett and E Madarasz. (2002). Stage-dependent effects of cell-to-cell connections on in vitro induced neurogenesis. Eur J Cell Biol 81:403-412.
55. Sharma SK and AB Raj. (1987). Transient increase in intracellular concentration of adenosine 3:5-cyclic monophosphate results in morphological and biochemical differentiation of C6 glioma cells in culture. J Neurosci Res 17:135-141.
56. Deng W, M Obrocka, I Fischer and DJ Prockop. (2001). In vitro differentiation of human marrow stromal cells into early progenitors of neural cells by conditions that increase intracellular cyclic AMP. Biochem Biophys Res Commun 282:148-152.
57. Bez A, E Corsini, D Curti, M Biggiogera, A Colombo, RF Nicosia, SF Pagano and EA Parati. (2003). Neurosphere and neurosphere-forming cells: morphological and ultrastructural characterization. Brain Res 993:18-29.
58. Zhao Y, T Zhang, Q Huang, A Wang, J Dong, Q Lan and Z Qin. (2009). Ultrastructure of human neural stem/ progenitor cells and neurospheres. Neural Regen Res 4:365-370.
59. Casper KB and KD McCarthy. (2006). GFAP-positive progenitor cells produce neurons and oligodendrocytes throughout the CNS. Mol Cell Neurosci 31:676-684.
60. Naruse M, K Shibasaki, S Yokoyama, M Kurachi and Y Ishizaki. (2013). Dynamic changes of CD44 expression from progenitors to subpopulations of astrocytes and neurons in developing cerebellum. PLoS One 8:e53109.
61. Pruszak J, W Ludwig, A Blak, K Alavian and O Isacson. (2009). CD15, CD24, and CD29 define a surface biomarker code for neural lineage differentiation of stem cells. Stem Cells 27:2928-2940.
62. Castro DS, B Martynoga, C Parras, V Ramesh, E Pacary, C Johnston, D Drechsel, M Lebel-Potter, LG Garcia, et al. (2011). A novel function of the proneural factor Ascl1 in progenitor proliferation identified by genome-wide characterization of its targets. Genes Dev 25:930-945.
63. Kim EJ, JL Ables, LK Dickel, AJ Eisch and JE Johnson. (2011). Ascl1 (Mash1) defines cells with long-term neurogenic potential in subgranular and subventricular zones in adult mouse brain. PLoS One 6:e18472.
64. Kosari F, CM Ida, MC Aubry, L Yang, IV Kovtun, JL Klein, Y Li, S Erdogan, SC Tomaszek, et al. (2014). ASCL1 and RET expression defines a clinically relevant subgroup of lung adenocarcinoma characterized by neuroendocrine differentiation. Oncogene 33:3776-3783.
65. Stein R, N Mori, K Matthews, LC Lo and DJ Anderson. (1988). The NGF-inducible SCG10 mRNA encodes a novel membrane-bound protein present in growth cones and abundant in developing neurons. Neuron 1:463-476.
66. Wuenschell CW, N Mori and DJ Anderson. (1990). Analysis of SCG10 gene expression in transgenic mice reveals that neural specificity is achieved through selective derepression. Neuron 4:595-602.
67. Saito A, P Narasimhan, T Hayashi, S Okuno, M Ferrand-Drake and PH Chan. (2004). Neuroprotective role of a proline-rich Akt substrate in apoptotic neuronal cell death after stroke: relationships with nerve growth factor. J Neurosci 24:1584-1593.
68. McTigue DM, PJ Horner, BT Stokes and FH Gage. (1998). Neurotrophin-3 and brain-derived neurotrophic factor induce oligodendrocyte proliferation and myelination of regenerating axons in the contused adult rat spinal cord. J Neurosci 18:5354-5365.
69. Lindsay RM. (1988). Nerve growth factors (NGF, BDNF) enhance axonal regeneration but are not required for survival of adult sensory neurons. J Neurosci 8:2394-2405.
70. Ghosh A, J Carnahan and ME Greenberg. (1994). Requirement for BDNF in activity-dependent survival of cortical neurons. Science 263:1618-1623.
71. Wetmore C, L Olson and AJ Bean. (1994). Regulation of brain-derived neurotrophic factor (BDNF) expression and release from hippocampal neurons is mediated by non-NMDA type glutamate receptors. J Neurosci 14(3 Pt 2):1688-1700.
72. Balkowiec A and DM Katz. (2002). Cellular mechanisms regulating activity-dependent release of native brainderived neurotrophic factor from hippocampal neurons. J Neurosci 22:10399-10407.
73. Hartmann M, R Heumann and V Lessmann. (2001). Synaptic secretion of BDNF after high-frequency stimulation of glutamatergic synapses. EMBO J 20:5887-5897.
74. Hock C, K Heese, C Hulette, C Rosenberg and U Otten. (2000). Region-specific neurotrophin imbalances in Alzheimer disease: decreased levels of brain-derived neurotrophic factor and increased levels of nerve growth factor in hippocampus and cortical areas. Arch Neurol 57:846-851.
75. Phillips HS, JM Hains, M Armanini, GR Laramee, SA Johnson and JW Winslow. (1991). BDNF mRNA is decreased in the hippocampus of individuals with Alzheimer's disease. Neuron 7:695-702.
76. Ploughman M, V Windle, CL MacLellan, N White, JJ Dore and D Corbett. (2009). Brain-derived neurotrophic factor contributes to recovery of skilled reaching after focal ischemia in rats. Stroke 40:1490-1495.
77. Schabitz WR, T Steigleder, CM Cooper-Kuhn, S Schwab, C Sommer, A Schneider and HG Kuhn. (2007). Intravenous brain-derived neurotrophic factor enhances poststroke sensorimotor recovery and stimulates neurogenesis. Stroke 38:2165-2172.
78. Scharfman HE, JH Goodman, AL Sollas and SD Croll. (2002). Spontaneous limbic seizures after intrahippocampal infusion of brain-derived neurotrophic factor. Exp Neurol 174:201-214.
79. Ding J, Y Cheng, S Gao and J Chen. (2011). Effects of nerve growth factor and Noggin-modified bone marrow stromal cells on stroke in rats. J Neurosci Res 89:222-230.
80. Barker PA. (2004). p75NTR is positively promiscuous: novel partners and new insights. Neuron 42:529-533.
81. Masoudi R, MS Ioannou, MD Coughlin, P Pagadala, KE Neet, O Clewes, SJ Allen, D Dawbarn and M Fahnestock. (2009). Biological activity of nerve growth factor precursor is dependent upon relative levels of its receptors. J Biol Chem 284:18424-18433.
82. Storkebaum E and P Carmeliet. (2004). VEGF: a critical player in neurodegeneration. J Clin Invest 113:14-18.
83. Sun Y, K Jin, L Xie, J Childs, XO Mao, A Logvinova and DA Greenberg. (2003). VEGF-induced neuroprotection, neurogenesis, and angiogenesis after focal cerebral ischemia. J Clin Invest 111:1843-1851.
84. Jin K, Y Zhu, Y Sun, XO Mao, L Xie and DA Greenberg. (2002). Vascular endothelial growth factor (VEGF) stimulates neurogenesis in vitro and in vivo. Proc Natl Acad Sci U S A 99:11946-11950.
85. Wang Y, E Kilic, U Kilic, B Weber, CL Bassetti, HH Marti and DM Hermann. (2005). VEGF overexpression induces post-ischaemic neuroprotection, but facilitates haemodynamic steal phenomena. Brain 128(Pt 1): 52-63.
86. Lambrechts D, E Storkebaum, M Morimoto, J Del-Favero, F Desmet, SL Marklund, S Wyns, V Thijs, J Andersson, et al. (2003). VEGF is a modifier of amyotrophic lateral sclerosis in mice and humans and protects motoneurons against ischemic death. Nat Genet 34:383-394.
87. Lin LF, DH Doherty, JD Lile, S Bektesh and F Collins. (1993). GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons. Science 260: 1130-1132.
88. Choi-Lundberg DL, Q Lin, YN Chang, YL Chiang, CM Hay, H Mohajeri, BL Davidson and MC Bohn. (1997). Dopaminergic neurons protected from degeneration by GDNF gene therapy. Science 275:838-841.
89. Beck KD, J Valverde, T Alexi, K Poulsen, B Moffat, RA Vandlen, A Rosenthal and F Hefti. (1995). Mesencephalic dopaminergic neurons protected by GDNF from axotomyinduced degeneration in the adult brain. Nature 373:339-341.
90. Kordower JH, ME Emborg, J Bloch, SY Ma, Y Chu, L Leventhal, J McBride, EY Chen, S Palfi, et al. (2000). Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson's disease. Science 290:767-773.
91. Palay SL and GE Palade. (1955). The fine structure of neurons. J Biophys Biochem Cytol 1:69-88.
92. Babst M, DJ Katzmann, WB Snyder, B Wendland and SD Emr. (2002). Endosome-associated complex, ESCRT-II, recruits transport machinery for protein sorting at the multivesicular body. Dev Cell 3:283-289.
93. Rind HB, R Butowt and CS von Bartheld. (2005). Synaptic targeting of retrogradely transported trophic factors in motoneurons: comparison of glial cell line-derived neurotrophic factor, brain-derived neurotrophic factor, and cardiotrophin-1 with tetanus toxin. J Neurosci 25:539-549.
94. Wislet-Gendebien S, G Hans, P Leprince, JM Rigo, G Moonen and B Rogister. (2005). Plasticity of cultured mesenchymal stem cells: switch fromnestin-positive to excitable neuron-like phenotype. Stem Cells 23:392-402.
95. Biella G, F Di Febo, D Goffredo, A Moiana, V Taglietti, L Conti, E Cattaneo and M Toselli. (2007). Differentiating embryonic stem-derived neural stem cells show a maturationdependent pattern of voltage-gated sodium current expression and graded action potentials. Neuroscience 149:38-52.
96. Zhang XQ and SC Zhang. (2010). Differentiation of neural precursors and dopaminergic neurons from human embryonic stem cells. Methods Mol Biol 584:355-366.
97. Elkabetz Y, G Panagiotakos, G Al Shamy, ND Socci, V Tabar and L Studer. (2008). Human ES cell-derived neural rosettes reveal a functionally distinct early neural stem cell stage. Genes Dev 22:152-165.
98. Lee H, GA Shamy, Y Elkabetz, CM Schofield, NL Harrsion, G Panagiotakos, ND Socci, V Tabar and L Studer. (2007). Directed differentiation and transplantation of human embryonic stem cell-derived motoneurons. Stem Cells 25:1931-1939.
99. Espuny-Camacho I, KA Michelsen, D Gall, D Linaro, A Hasche, J Bonnefont, C Bali, D Orduz, A Bilheu, et al. (2013). Pyramidal neurons derived from human pluripotent stem cells integrate efficiently into mouse brain circuits in vivo. Neuron 77:440-456.
100. Liu L, X Wei, J Ling, L Wu and Y Xiao. (2011). Expression pattern of Oct-4, Sox2, and c-Myc in the primary culture of human dental pulp derived cells. J Endod 37: 466-472.
101. Atari M, C Gil-Recio, M Fabregat, D Garcia-Fernandez, M Barajas, MA Carrasco, HS Jung, FH Alfaro, N Casals, et al. (2012). Dental pulp of the third molar: a new source of pluripotent-like stem cells. J Cell Sci 125(Pt 14):3343-3356.